Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 3 of the 11 sources its claims cite were checked for support.
Abstract
The quantitative contributions of pancreatic responsiveness and insulin sensitivity to glucose tolerance were measured using the "minimal modeling technique" in 18 lean and obese subjects (88-206% ideal body wt). The individual contributions of insulin secretion and action were measured by interpreting the dynamics of plasma glucose and insulin during the intravenous glucose tolerance test in terms of two mathematical models. One, the insulin kinetics model, yields parameters of first-phase (phi 1) and second-phase (phi 2) responsivity of the beta-cells to glucose. The other glucose kinetics model yields the insulin sensitivity parameters, SI. Lean and obese subjects were subdivided into good (KG greater than 1.5) and lower (KG less than 1.5) glucose tolerance groups. The etiology of lower glucose tolerance was entirely different in lean and obese subjects. Lean, lower tolerance was related to pancreatic insufficiency (phi 2 77% lower than in good tolerance controls [P less than 0.03]), but insulin sensitivity was normal (P greater than 0.5). In contrast, obese lower tolerance was entirely due to insulin resistance (SI diminished 60% [P less than 0.01]); pancreatic responsiveness was not different from lean, good tolerance controls (phi 1: P greater than 0.06; phi 2: P greater than 0.40). Subjects (regardless of weight) could be segregated into good and lower tolerance by the product of second-phase beta-cell responsivity and insulin sensitivity (phi 2 . SI). Thus, these two factors were primarily responsible for overall determination of glucose tolerance. The effect of phi 1 was to modulate the KG value within those groups whose overall tolerance was determined by phi 2 . SI. This phi 1 modulating influence was more pronounced among insulin sensitive (phi 1 vs. KG, r = 0.79) than insulin resistant (obese, low tolerance; phi 1 vs. KG, r = 0.91) subjects. This study demonstrates the feasibility of the minimal model technique to determine the etiology of impaired glucose tolerance.
Overview
CoChat Summary
TL;DR
The paper applies the “minimal modeling” technique to intravenous glucose tolerance tests in 18 lean and obese subjects to quantify insulin sensitivity and β-cell glucose responsiveness. It finds that low glucose tolerance in lean subjects is due mainly to pancreatic insufficiency, whereas in obese subjects it is due mainly to insulin resistance.
Key findings
- Lean subjects with lower glucose tolerance had a 77% lower second-phase β-cell responsivity (φ2) than lean good-tolerance controls (P < 0.03), while insulin sensitivity was normal (P > 0.5).
- Obese subjects with lower glucose tolerance had insulin sensitivity diminished by 60% versus lean good-tolerance controls (P < 0.01), with pancreatic responsiveness not significantly different (φ1: P > 0.06; φ2: P > 0.40).
- The product φ2·S segregated tolerance: good-tolerance subjects averaged 160 ± 26 versus 40 ± 7 for low-tolerance subjects (P < 0.001); a φ2·S threshold of 75 separated 9 of 10 low-tolerance and 7 of 8 good-tolerance subjects.
- First-phase responsivity (φ1) modulated KG within groups: φ1 vs KG correlated r = 0.79 in insulin-sensitive subjects and r = 0.91 in insulin-resistant obese low-tolerance subjects; glucose effectiveness (P1) was lower in low-tolerance subjects (1.4 ± 0.2 vs. 3.6 ± 0.3 %/min, P < 0.01).
Methods
- IVGTT was performed in 18 subjects (8 male, 10 female; 88–206% ideal body weight) after an overnight fast, with 300 mg/kg glucose injected over 60 s and frequent plasma glucose and insulin sampling.
- Two minimal mathematical models were used: a glucose kinetics model to estimate insulin sensitivity (S) and an insulin kinetics model to estimate first-phase (φ1) and second-phase (φ2) β-cell responsivity to glucose.
- Parameters were estimated by nonlinear least squares with covariance-matrix accuracy assessment; subjects were divided into good tolerance (KG > 1.5) and lower tolerance (KG < 1.5), and comparisons used Student’s t test and regression.
Limitations
- The paper states that complete validation of the model and optimal input patterns is required before the approach can be proposed as a clinical tool, and that more study of the range of glucose doses over which the model applies would be worthwhile.
- The authors note that the present studies were limited to testing whether the model and its parameters apply and can be obtained from other doses and stimulus patterns.
- Evident from the text: the sample is small (n = 18), the tolerance cutoff at KG = 1.5 was arbitrary because no KG values fell between 1.4 and 1.8, and φ1 varied widely within groups, limiting clear segregation by φ1·S.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![FiGURE 4 Ability of the minimal models to describe glucose and insulin kinetics during the IVGTT (examples). Insulin and glucose data are represented by open (O) and filled () circles. Prediction of the insulin kinetics model are the solid curves; upper panels. Glucose kinetics model predicts the time-course of plasma glucose (solid curves, lower panels) as well as the timecourse of "insulin action" (dashed line upper panels; remote insulin [X] in the model of Fig. la).](https://figures.cochat.ai/paper-figures/f6e06f75ebdc4bef964605372991c28c/physiologic-evaluation-of-factors-controlling-glucose-tolerance-in-man-figure-4.png)



Verification
Claims the paper makes
2 Valid · 0 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During the past decade, several laboratories have approached this problem by breaking the feedback relationship, either by pharmacological suppression of pancreatic insulin secretion (10) or by external feedback control (glucose clamp) to circumvent the effect of plasma insulin to change plasma glucose (11).”
What the sources say
- Supportedcites [10] 10. Shen, S-W., G. M. Reaven, and J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects.J. Clin. Invest. 49: 2151-2160. source
The Introduction (p. 1, 'Dr. Shen is a Postdoctoral Research Fellow' section) states the approach the citing sentence attributes to this reference: subjects received a constant intravenous infusion of exogenous crystalline insulin while 'endogenous insulin secretion was inhibited by the simultaneous administration of low doses of epinephrine and propranolol,' so that the steady-state plasma glucose during a constant glucose infusion measures impedance to insulin-mediated glucose uptake, and such measurements 'should eliminate some of the variables of an intact feedback loop.' The Discussion ('§ Values obtained from') confirms the pharmacological blockade worked (immunoreactive insulin fell to <50% of fasting and remained low despite plasma glucose of 316 and 398 mg/100 ml), and that its primary goal was to consider only a constant level of exogenous insulin. Our copy does not describe external feedback control (glucose clamp), but that half of the sentence is carried by the separate citation (11), not by this source; likewise 'during the past decade, several laboratories' is the citing authors' framing. Note the propranolol-epinephrine inhibition method is credited to Porte (ref 36), but Shen et al. report and rely on it as their own experimental approach, so the identification citation stands. (LLM, conf=0.88)
- Supportedcites [11] 11. Insel, P. A., J. E. Liljenquist, J. D. Tobin, R. S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55: 1057-1066. source
The citation is attached to the glucose-clamp branch of the sentence (the pharmacological-suppression branch carries a different reference), and our copy is exactly that kind of work: the Introduction (p. 1057) states that 'the maintenance of blood sugar in man is a complex process involving feedback control of insulin on glucose and of glucose on insulin' and that 'by use of the glucose clamp technique (1, 2), the blood glucose concentration is maintained by a feedback-controlled glucose infusion.' The Abstract (p. 1057) confirms the purpose — insulin-induced changes in blood glucose activate counterregulatory mechanisms, 'to eliminate such mechanisms, we have employed the glucose clamp technique which allows maintenance of fasting blood glucose concentration,' and the Discussion (p. 1063) presents the clamp (with kinetic modeling) as an approach to estimating tissue sensitivity to insulin, contrasting it with the insulin tolerance test and 'glucose impedance.' The 'several laboratories' framing is the citing authors' own summary, not a point attributed to this source. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thus, our results are consistent with the diminished S of obese subjects elucidated by both qualitative (26) and quantitative techniques (25).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Kolterman, O., G. M. Reaven, and J. M. Olefsky. 1979. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men. J. Clin. Endocrinol. Metab. 48: 487-494. source
- Supportedcites [25] 25. DeFronzo, R., V. Soman, R. Sherwin, R. Hendler, and P. Felig. 1979. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J. Clin. Invest. 63: 204–213. source
The citation is attached to “quantitative techniques.” The Discussion reports that insulin sensitivity was quantified with the euglycemic insulin clamp and was 52% lower in postabsorptive obese subjects. This supports the attributed finding of diminished insulin sensitivity (S); the qualitative-techniques citation is separate. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the obese glucose space exceeded the space of lean individuals by only 16% (Table II).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an increase of φ1 from 1 to 10 was associated with an increase in KG of only 0.3 min−¹.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because the diminished glucose effectiveness of obese subjects is independent of acute changes in insulin”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 50 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have demonstrated that to maintain glucose homeostasis, a feedback loop exists in which decreased insulin sensitivity is tightly associated with increased insulin secretion from the beta cell, with this hyperbolic relationship between beta cell responsivity and insulin sensitivity termed the disposition index67,68.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [68]
Experimental — accuracy not yet measuredIn the citing paper
“the product of insulin sensitivity and the acute insulin response to intravenous glucose, called the disposition index [93], declined in the group as a whole and was associated with a mild deterioration of intravenous glucose tolerance.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 6 | 1.06 | 8.9 | 5.1 | 1.4 | 4.5 |”
Reported 4.5 · recomputed 45.39
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 7
“In the glucose kinetics model (Fig. 1b) the coefficient P1 is the insulin-independent fractional turnover constant for glucose disposition”
§ B MINIMAL MODEL OF INSULIN KINETICS · p. 3
“(B) Model of insulin kinetics used to calculate pancreatic responsivity parameters φ1 and φ2 (12).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS · p. 2
“glucose (300 mg/kg) was injected smoothly over 60 s, starting at time (t) = 0.”
§ RESULTS · p. 6
“Glucose (330 mg/kg) was injected over 1 min starting at t = 0.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1172/jci109108 · retraction date not known · this paper published 1981-12-01
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedQuantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 4×
“We have referred to the sum of these factors as "glucose effectiveness" (13).”
InfluentialSelf-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 395
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Statistical Analysis: A Computer Oriented Approach.
Pektau, A. J., Afifi, A. A., & Azen, S. P. (1980) · Journal of the American Statistical Association · doi:10.2307/2287217 · Cited by 324
Toffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Self-citation
Research works printed but not linked: 2
- [18]18. Goodwin, C., and R. L. Payne. 1977. Dynamic System Identification. Academic Press, Inc., New York.
- [14]14. Bergman, R. N., C. R. Bowden, and C. Cobelli. 1981. The minimal model approach to quantification of factors controlling glucose disposal in man. In Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling. C. Cobelli, and R. Bergman, editors. John Wiley & Sons, Inc., London. 269–296.
Cited by
Items 101–200 of 1,647
Godsland, I. F., Gangar, K., Walton, C., Cust, M. P., Whitehead, M. I., Wynn, V., & Stevenson, J. C. (1993) · Metabolism · doi:10.1016/0026-0495(93)90058-v · Cited by 213
Lin, J., Razak, N. N., Pretty, C. G., Le Compte, A., Docherty, P., Parente, J. D., Shaw, G. M., Hann, C. E., & Geoffrey Chase, J. (2011) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.12.008 · Cited by 215
Minimal Model: Perspective from 2005
Bergman, R. N. (2005) · Hormone Research in Paediatrics · doi:10.1159/000089312 · Cited by 214
Self-citationModel-based blood glucose control for type 1 diabetes via parametric programming
Dua, P., Doyle, F. J., & Pistikopoulos, E. N. (2006) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.878075 · Cited by 198
Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies
Giacca, A., Xiao, C., Oprescu, A. I., Carpentier, A. C., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2010 · Cited by 196
Abnormalities in insulin secretion in type 2 diabetes mellitus
Guillausseau, P.-J., Meas, T., Virally, M., Laloi-Michelin, M., Médeau, V., & Kevorkian, J.-P. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73394-9 · Cited by 190
ISMRM workshop on fat–water separation: Insights, applications and progress in MRI
Hu, H. H., Börnert, P., Hernando, D., Kellman, P., Ma, J., Reeder, S., & Sirlin, C. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24369 · Cited by 189
Obesity, diabetes and the central nervous system
Porte Jr., D., Seeley, R. J., Woods, S. C., Baskin, D. G., Figlewicz, D. P., & Schwartz, M. W. (1998) · Diabetologia · doi:10.1007/s001250051002 · Cited by 186
“Moreover, while plasma leptin levels are, like fasting insulin levels, inversely associated with the prevailing level of insulin sensitivity [104], this relationship is dependent on the correlation between body adiposity and leptin levels [86], while fasting insulin levels are correlated with insulin sensitivity indep…”
BackgroundFINEGOOD, D. T., HRAMIAK, I. M., & DUPRE, J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1538 · Cited by 183
The biochemical assessment of insulin resistance
Borai, A., Livingstone, C., & Ferns, G. A. A. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780945778 · Cited by 184
Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications
Daly, M., Vale, C., Walker, M., Alberti, K., & Mathers, J. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.5.1072 · Cited by 182
An integrated mathematical model of the dynamics of blood glucose and its hormonal control
Cobelli, C., Federspil, G., Pacini, G., Salvan, A., & Scandellari, C. (1982) · Mathematical Biosciences · doi:10.1016/0025-5564(82)90050-5 · Cited by 182
Self-citationTwo-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Dalla Man, C., Campioni, M., Polonsky, K. S., Basu, R., Rizza, R. A., Toffolo, G., & Cobelli, C. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3265 · Cited by 179
“This enables determination of whether -cell function is appropriate for the prevailing level of insulin action (10,11).”
BackgroundSelf-citationFirst-phase insulin secretion: does it exist in real life? Considerations on shape and function
Caumo, A., & Luzi, L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00139.2003 · Cited by 174
Yarali, H. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.289 · Cited by 173
Morning Circadian Misalignment during Short Sleep Duration Impacts Insulin Sensitivity
Eckel, R. H., Depner, C. M., Perreault, L., Markwald, R. R., Smith, M. R., McHill, A. W., Higgins, J., Melanson, E. L., & Wright, K. P. (2015) · Current Biology · doi:10.1016/j.cub.2015.10.011 · Cited by 171
Role of Diet in the Treatment of Polycystic Ovary Syndrome
Douglas, C. C., Gower, B. A., Darnell, B. E., Ovalle, F., Oster, R. A., & Azziz, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.08.045 · Cited by 170
“, Department of Physiology and Biophysics, University of Southern California, Los Angeles) for determination of Si, the acute insulin response to glucose (AIRg), and the disposition index (DI = Si × AIRg) (32, 33).”
BackgroundLong, N. M., George, L. A., Uthlaut, A. B., Smith, D. T., Nijland, M. J., Nathanielsz, P. W., & Ford, S. P. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-3083 · Cited by 170
Blood glucose control for type I diabetes mellitus: A robust tracking H∞ problem
Ruiz-Velázquez, E., Femat, R., & Campos-Delgado, D. U. (2004) · Control Engineering Practice · doi:10.1016/j.conengprac.2003.12.004 · Cited by 167
Health Profile of Young Adults Born Preterm: Negative Effects of Rapid Weight Gain in Early Life
Kerkhof, G. F., Willemsen, R. H., Leunissen, R. W. J., Breukhoven, P. E., & Hokken-Koelega, A. C. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1716 · Cited by 167
Pancreatic iron and glucose dysregulation in thalassemia major
Noetzli, L. J., Mittelman, S. D., Watanabe, R. M., Coates, T. D., & Wood, J. C. (2012) · American Journal of Hematology · doi:10.1002/ajh.22223 · Cited by 168
Glucose Intolerance in a Large Cohort of Mediterranean Women With Polycystic Ovary Syndrome
Gambineri, A., Pelusi, C., Manicardi, E., Vicennati, V., Cacciari, M., Morselli-Labate, A. M., Pagotto, U., & Pasquali, R. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2353 · Cited by 168
Appleton, D., Rand, J., & Sunvold, G. (2001) · Journal of Feline Medicine and Surgery · doi:10.1053/jfms.2001.0138 · Cited by 166
Insulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159
β-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth
Weiss, R., Caprio, S., Trombetta, M., Taksali, S. E., Tamborlane, W. V., & Bonadonna, R. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1735 · Cited by 164
Davy, B. M., Davy, K. P., Ho, R. C., Beske, S. D., Davrath, L. R., & Melby, C. L. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.351 · Cited by 161
“This model uses measurements of plasma glucose and insulin concentrations over a 3-h period to derive in vivo whole-body SI (23).”
MethodEmery, A. F., & Nenarokomov, A. V. (1998) · Measurement Science and Technology · doi:10.1088/0957-0233/9/6/003 · Cited by 158
Succurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., & Sesti, G. (2008) · Obesity · doi:10.1038/oby.2008.308 · Cited by 158
Treiber, K. H., Kronfeld, D. S., Hess, T. M., Boston, R., & Harris, P. A. (2005) · American Journal of Veterinary Research · doi:10.2460/ajvr.2005.66.2114 · Cited by 182
The effect of physical exercise on the dynamics of glucose and insulin
Derouich, M., & Boutayeb, A. (2002) · Journal of Biomechanics · doi:10.1016/s0021-9290(02)00055-6 · Cited by 161
SWINBURN, B. A., BOYCE, V. L., BERGMAN, R. N., HOWARD, B. V., & BOGARDUS, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-156 · Cited by 155
Self-citationInsulin Resistance and β-Cell Dysfunction in Aging: The Importance of Dietary Carbohydrate*
CHEN, M., BERGMAN, R. N., & PORTE, D. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-5-951 · Cited by 155
Self-citationMirhosseini, N., Vatanparast, H., Mazidi, M., & Kimball, S. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01024 · Cited by 155
Kowalski, G. M., & Bruce, C. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2014 · Cited by 154
“Conversely, pharmacological inhibition of lipolysis can improve insulin action and glucose metabolism in T2D patients and healthy controls alike (23, 50).”
BackgroundInfluentialEllingsen, C., Dassau, E., Zisser, H., Grosman, B., Percival, M. W., Jovanovič, L., & Doyle, F. J. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300319 · Cited by 153
The impact of mathematical modeling on the understanding of diabetes and related complications
Ajmera, I., Swat, M., Laibe, C., Le Novère, N., & Chelliah, V (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.30 · Cited by 153
“Nucleus Nucleus Nucleus ER Mitochondria Mitochondria TCA TCA PI(3)K Insulin”
MethodEffects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes
Bradley, D., Magkos, F., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.114 · Cited by 152
Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology
de Graaf, A. A., Freidig, A. P., De Roos, B., Jamshidi, N., Heinemann, M., Rullmann, J. A. C., Hall, K. D., Adiels, M., & van Ommen, B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000554 · Cited by 153
Hull, R. L., Kodama, K., Utzschneider, K. M., Carr, D. B., Prigeon, R. L., & Kahn, S. E. (2005) · Diabetologia · doi:10.1007/s00125-005-1772-9 · Cited by 167
Ethnicity, type 2 diabetes & migrant Asian Indians.
Abate, N., & Chandalia, M. (2007) · PubMed · Cited by 183
Laakso, M., Zilinskaite, J., Hansen, T. F., Boesgaard, T. W., Vänttinen, M., Stančáková, A., Jansson, P., Pellmé, F., Holst, J. J., Kuulasmaa, T., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0899-2 · Cited by 158
Altered D-Chiro-Inositol Urinary Clearance in Women With Polycystic Ovary Syndrome
Baillargeon, J.-P., Diamanti-Kandarakis, E., Ostlund, R. E., Apridonidze, T., Iuorno, M. J., & Nestler, J. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1070 · Cited by 146
Dixon, J. B., Dixon, A. F., & O'Brien, P. E. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00889.x · Cited by 147
Lee, S., Choi, S., Kim, H. J., Chung, Y.-S., Lee, K. W., Lee, H. C., Huh, K. B., & Kim, D. J. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.4.695 · Cited by 147
Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion
Wang, H., Chu, W. S., Lu, T., Hasstedt, S. J., Kern, P. A., & Elbein, S. C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00231.2003 · Cited by 146
Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications
Retnakaran, R. R., Hanley, A. J., Raif, N., Hirning, C. R., Connelly, P. W., Sermer, M., Kahn, S. E., & Zinman, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1710-x · Cited by 162
Azen, S. P., Peters, R. K., Berkowitz, K. M., Kjos, S. L., Xiang, A. H., & Buchanan, T. A. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00151-7 · Cited by 153
Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?
Bergman, R. N. (2000) · Diabetologia · doi:10.1007/s001250051474 · Cited by 170
Self-citationDynamic Modeling of Exercise Effects on Plasma Glucose and Insulin Levels
Roy, A., & Parker, R. S. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100305 · Cited by 147
β-Cell function in type 2 diabetes
Ferrannini, E., & Mari, A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.012 · Cited by 168
Cobelli, C., Pacini, G., Toffolo, G., & Sacca, L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.5.e591 · Cited by 140
Self-citationXiao, C., Giacca, A., Carpentier, A. C., & Lewis, G. F. (2006) · Diabetologia · doi:10.1007/s00125-006-0211-x · Cited by 155
Li, C., Johnson, M. S., & Goran, M. I. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2035 · Cited by 150
Watanabe, R. M., Ghosh, S., Langefeld, C. D., Valle, T. T., Hauser, E. R., Magnuson, V. L., Mohlke, K. L., Silander, K., Ally, D. S., Chines, P. S., et al. (2000) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)62949-8 · Cited by 146
Self-citationIbanez, L., Potau, N., Zampolli, M., Prat, N., Virdis, R., Vicens-Calvet, E., & Carrascosa, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772605 · Cited by 138
Simonis-Bik, A. M., Nijpels, G., van Haeften, T. W., Houwing-Duistermaat, J. J., Boomsma, D. I., Reiling, E., van Hove, E. C., Diamant, M., Kramer, M. H. H., Heine, R. J., et al. (2010) · Diabetes · doi:10.2337/db09-1048 · Cited by 137
Turksoy, K., Samadi, S., Feng, J., Littlejohn, E., Quinn, L., & Çınar, A. (2015) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2015.2446413 · Cited by 156
The Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism
Sjögren, K., Wallenius, K., Liu, J.-L., Bohlooly-Y, M., Pacini, G., Svensson, L., Törnell, J., Isaksson, O. G. P., Ahrén, B., Jansson, J.-O., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1539 · Cited by 136
Assessment of insulin sensitivity in vivo: A critical review
Bergman, R. N., Hope, I. D., Yang, Y. J., Watanabe, R. M., Meador, M. A., Youn, J. H., & Ader, M. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050501 · Cited by 143
Self-citationMalka, R., Nathan, D. M., & Higgins, J. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9304 · Cited by 134
Watanabe, R. M., Allayee, H., Xiang, A. H., Trigo, E., Hartiala, J., Lawrence, J. M., & Buchanan, T. A. (2007) · Diabetes · doi:10.2337/db06-1682 · Cited by 132
Arends, N. J. T., Boonstra, V. H., Duivenvoorden, H. J., Hofman, P. L., Cutfield, W. S., & Hokken‐Koelega, A. C. S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02171.x · Cited by 132
Åhrén, B., Simonsson, E., Scheurink, A. J. W., Mulder, H., Myrsén-Axcrona, U., & Sundler, F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90175-x · Cited by 138
Perilipin Expression in Human Adipose Tissue Is Elevated with Obesity
Kern, P. A., Gregorio, G. B. D., Lu, T., Rassouli, N., & Ranganathan, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031388 · Cited by 142
Cheang, K. I., Baillargeon, J.-P., Essah, P. A., Ostlund, R. E., Apridonize, T., Islam, L., & Nestler, J. E. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.008 · Cited by 129
Clinical Significance of the Insulin Resistance Index as Assessed by Homeostasis Model Assessment.
Ikeda, Y., Suehiro, T., Nakamura, T., Kumon, Y., & Hashimoto, K. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.81 · Cited by 137
Insulin sensitivity by oral glucose minimal models: validation against clamp
Dalla Man, C., Yarasheski, K. E., Caumo, A., Robertson, H., Toffolo, G., Polonsky, K. S., & Cobelli, C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00076.2005 · Cited by 128
Self-citationβ-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes
Festa, A., Williams, K., Hanley, A. J. G., & Haffner, S. M. (2008) · Diabetes · doi:10.2337/db07-0954 · Cited by 128
Lindheim, S. R., Buchanan, T. A., Duffy, D. M., Vijod, M. A., Kojima, T., Stanczyk, F. Z., & Løbo, R. A. (1994) · Journal of the Society for Gynecologic Investigation · doi:10.1177/107155769400100210 · Cited by 142
Evidence of Reduced β-Cell Function in Asian Indians With Mild Dysglycemia
Staimez, L. R., Weber, M. B., Ranjani, H., Ali, M. K., Echouffo-Tcheugui, J. B., Phillips, L. S., Mohan, V., & Narayan, K. M. V. (2013) · Diabetes Care · doi:10.2337/dc12-2290 · Cited by 313
Self-citationBlood glucose control algorithms for type 1 diabetic patients: A methodological review
Lunze, K., Singh, T., Walter, M., Brendel, M. D., & Leonhardt, S. K. (2012) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2012.09.003 · Cited by 140
Functional impact of high protein intake on healthy elderly people
Walrand, S., Short, K. R., Bigelow, M. L., Sweatt, A. J., Hutson, S. M., & Nair, K. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90536.2008 · Cited by 125
Hanley, A. J. G., Wagenknecht, L. E., D’Agostino, R. B., Zinman, B., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2740 · Cited by 126
The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas
Bothe, M. K., Dickens, L., Reichel, K., Tellmann, A., Ellger, B., Westphal, M., & Faisal, A. A. (2013) · Expert Review of Medical Devices · doi:10.1586/17434440.2013.827515 · Cited by 124
Jacobsson, J. A., Danielsson, P., Svensson, V., Kloviņš, J., Gyllensten, U. B., Marcus, C., Schiöth, H. B., & Fredriksson, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.087 · Cited by 135
Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus
Owens, C., Zisser, H., Jovanovic, L., Srinivasan, B., Bonvin, D., & Doyle, F. J. (2006) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.872818 · Cited by 122
Pestell, R. G., ALFORD, F. P., RAMOS, R., SAWYER, S., Best, J. D., & Ward, G. M. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03885.x · Cited by 120
D'Alessio, D. A., Vogel, R., Prigeon, R., Laschansky, E., Koerker, D., Eng, J., & Ensinck, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118380 · Cited by 122
Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function
Sørensen, H., Winzell, M. S., Brand, C. L., Fosgerau, K., Gelling, R. W., Nishimura, E., & Ahren, B. (2006) · Diabetes · doi:10.2337/db06-0307 · Cited by 121
Vrachnis, N., Belitsos, P., Sifakis, S., Dafopoulos, K., Siristatidis, C., Pappa, K. I., & Iliodromiti, Z. (2012) · International Journal of Endocrinology · doi:10.1155/2012/549748 · Cited by 119
Tura, A., Ludvik, B., Nolan, J. J., Pacini, G., & Thomaseth, K. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.5.e966 · Cited by 120
Lindquist, C., Gower, B. A., & Goran, M. I. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.3.725 · Cited by 134
Ciampelli, M., Leoni, F., Cucinelli, F., Mancuso, S., Panunzi, S., De Gaetano, A., & Lanzone, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0410 · Cited by 118
Evidence for a Role of Superoxide Generation in Glucose-Induced β-Cell Dysfunction In Vivo
Tang, C., Han, P., Oprescu, A. I., Lee, S. C., Gyulkhandanyan, A. V., Chan, G. N. Y., Wheeler, M. B., & Giacca, A. (2007) · Diabetes · doi:10.2337/db07-0279 · Cited by 119
Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome
Laaksonen, D. E., Toppinen, L., Juntunen, K. S., Autio, K., Liukkonen, K. H., Poutanen, K. S., NISKANEN, L. K., & Mykkänen, H. M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1218 · Cited by 132
Control-relevant modeling in drug delivery
Parker, R. S., & Doyle, F. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00114-4 · Cited by 127
Lynch, S. M., & Bequette, B. W. (2002) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2002.1024561 · Cited by 119
Watanabe, R. M., Valle, T., Hauser, E. R., Ghosh, S., Eriksson, J., Kohtamäki, K., Ehnholm, C., Tuomilehto, J., Collins, F. S., Bergman, R. N., et al. (1999) · Human Heredity · doi:10.1159/000022865 · Cited by 117
Self-citationGoran, M. I., Bergman, R. N., & Gower, B. A. (2001) · Obesity Research · doi:10.1038/oby.2001.56 · Cited by 129
Self-citationEffects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114
“two measures, therefore remains constant in individuals with comparable glucose tolerance, but declines directly with impaired glucose tolerance (20; 21).”
Improved β-cell function after standardized weight reduction in severely obese subjects
Guldstrand, M., Ahrén, B., & Adamson, U. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00325.2002 · Cited by 115
Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice
Pacini, G., Thomaseth, K., & Ahrén, B. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e693 · Cited by 115
Orchestration of Glucose Homeostasis
Bergman, R. N. (2007) · Diabetes · doi:10.2337/db07-9903 · Cited by 114
Self-citationSimultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp
Mitrakou, A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.379 · Cited by 117
Gower, B. A., Granger, W. M., Franklin, F., Shewchuk, R. M., & Goran, M. I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8498 · Cited by 114
Galvin, P., Ward, G., Walters, J., Pestell, R., Koschmann, M., Vaag, A., Martin, I., Best, J. D., & Alford, F. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01732.x · Cited by 112
George, L. A., Zhang, L., Tuersunjiang, N., Ma, Y., Long, N. M., Uthlaut, A. B., Smith, D. T., Nathanielsz, P. W., & Ford, S. P. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00241.2011 · Cited by 112
Sugars, insulin sensitivity, and the postprandial state
Daly, M. E. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.865s · Cited by 119
Pacini, G., Tonolo, G., Sambataro, M., Maioli, M., Ciccarese, M., Brocco, E., Avogaro, A., & Nosadini, R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.4.e592 · Cited by 111
Metadata
- Authors
- Bergman, R. N., Phillips, L. S., & Cobelli, C.
- Affiliations
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-12-01
- Volume
- 68
- Issue
- 6
- Pages
- 1456-1467
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370948
- OpenAlex
- W2156353972
- Cited by
- 1,640
- References
- 30
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 44 · 2023: 31 · 2022: 45 · 2021: 59 · 2020: 50 · 2019: 55 · 2018: 66 · 2017: 66 · 2016: 59 · 2015: 63 · 2014: 60 · 2013: 59 · 2012: 73
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose tolerance, insulin sensitivity, beta-cell glucose sensitivity, insulin resistance, pancreatic insufficiency, intravenous glucose tolerance test, first-phase insulin response, second-phase insulin response, obesity, impaired glucose tolerance, insulin kinetics, glucose kinetics
- MeSH terms
- Body Weight, Female, Glucose, Glucose Tolerance Test, Humans, Infusions, Parenteral, Insulin, Kinetics, Male, Models, Biological, Obesity, Pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.